Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.25
1.33%
After-hours: Aug 15, 2025, 06:59 PM EDT
Cidara Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -25.72M | -23.48M | -52.31M | -12.98M | -89.41M | -10.33M | -5.61M | -8.17M | -12.36M | 3.01M | -13.38M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M |
Depreciation & Amortization | 27K | 49K | 59K | 61K | 57K | 56K | 39K | 22K | -263K | 32K | 315K | 310K | 303K | 297K | -1.42M | 117K | 34K | 40K |
Stock-Based Compensation | 2.96M | 1.74M | 1.66M | 751K | 703K | 795K | 830K | 796K | 795K | 640K | 673K | 843K | 678K | 1.34M | 1.36M | 901K | 871K | 879K |
Other Working Capital | -1.84M | -2.95M | 15.44M | -25.64M | -22.78M | -331K | 2.91M | 1.26M | -3.73M | 1.78M | -3.68M | 10.28M | -3.65M | -3.54M | 3.13M | 5.81M | -5.04M | 4.2M |
Other Non-Cash Items | -9.13M | 422K | 307K | -2.7M | 460K | 220K | 2.69M | 270K | 229K | 737K | -1.77M | 1.77M | 523K | 1K | 3K | 2K | 6K | 4K |
Deferred Income Tax | 5.51M | -5.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -523K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -14.6M | 4.83M | 20.87M | -21.82M | -15.59M | 2.61M | -10.67M | 5.45M | 14.42M | -15.32M | -6.84M | 10.07M | 302K | -6.96M | 1.95M | 5.09M | -8.18M | 15.58M |
Operating Cash Flow | -40.96M | -21.95M | -29.41M | -36.7M | -103.78M | -6.64M | -12.72M | -1.63M | 2.82M | -10.9M | -21M | 27.97M | -11.84M | -23.61M | -14.91M | -11.97M | 3.44M | -1.79M |
Capital Expenditures | n/a | n/a | n/a | -106K | n/a | -23K | -178K | -126K | -107K | -94K | -9K | -9K | -16K | -84K | n/a | -12K | -17K | -12K |
Cash Acquisitions | n/a | 185K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 185K | n/a | -106K | n/a | -23K | -178K | -126K | -107K | -94K | -9K | -9K | -16K | -84K | n/a | -12K | -17K | -12K |
Debt Repayment | n/a | -50K | -76K | -75K | -75K | -50K | n/a | n/a | n/a | n/a | n/a | -371K | -1.11M | -1.11M | -1.11M | -1.11M | -1.11M | -1.11M |
Common Stock Repurchased | n/a | n/a | 39K | n/a | n/a | n/a | n/a | 63K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 137K | n/a | 46K | n/a | 4K | -39K | 7K | n/a | n/a | 14K | n/a | -720K | n/a | n/a | n/a | n/a | 5K | 1K |
Financial Cash Flow | 383.38M | 77K | 98.2M | -182K | 239.13M | -93K | 8K | n/a | -261K | 26.24M | 664K | 107K | -1.11M | -611K | 36.88M | -810K | 887K | 7.64M |
Net Cash Flow | 342.42M | -21.69M | 68.79M | -36.98M | 135.35M | -6.76M | -12.89M | -1.76M | 2.45M | 15.24M | -20.35M | 28.07M | -12.96M | -24.3M | 21.97M | -12.79M | 4.31M | 5.84M |
Free Cash Flow | -40.96M | -21.95M | -29.41M | -36.8M | -103.78M | -6.67M | -12.9M | -1.76M | 2.71M | -10.99M | -21.01M | 27.96M | -11.85M | -23.69M | -14.91M | -11.98M | 3.42M | -1.8M |